CYCLOOXYGENASE REGULATION WITH PG LIPOSOMES

摘要

Cyclooxygenase-related inflammatory and pain-causing disorders in a mammalian subject can be alleviated by reducing the pathological expression of the COX-2 gene in the mammalian patient, by administration thereto of bodies, such as liposomes, beads or similar particles, of a size and conformation resembling mammalian apoptotic cells or apoptotic bodies, and which carry as a major component on their surface at least one phospholipid having as exteriorly presented head groups phosphato glycerol and synthetic mimetics thereof.